What is OncoVerity worth?
$63.0Mlast known valuation
OncoVerity last raised $14.0M in its Early Stage VC (Nov 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for OncoVerity
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2024 | Early Stage VC | $14.0M | ▮ | ▮ |
| Jul 2022 | Seed Round | $4.0M | ▮ | ▮ |
How OncoVerity's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For OncoVerity, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is OncoVerity worth?
- OncoVerity's last known valuation is $63.0M.
- How much has OncoVerity raised?
- OncoVerity has raised $44.0M in total funding across 2 recorded rounds.
- When did OncoVerity last raise?
- OncoVerity last raised in Nov 2024 (Early Stage VC), raising $14.0M.